Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC) in Patients With Metastatic or Recurrent Cancer of the Endometrium

NCT00249990 is registered in ClinicalTrials.gov with University of New Mexico as lead sponsor.

NCT NCT00249990
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00249990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC) in Patients With Metastatic or Recurrent Cancer of the Endometrium
Lead sponsor
University of New Mexico
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2003
Completion date
September 30, 2007
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corpus uteri, endometrial cancer